Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
0,05% 1,2- 0.01-0.1
EC/CAS
247-500-7/26172-55-4
Name of the chemical
5-chloro-2-methyl-4-thiazoline-3-ketone
Concentration
0.001-0.01
General Information
Version
2.16
Revision date
2023-07-26
Product name
GAMAZYME FRESH
Product Synonyms
Not Available
Chemical name
Not Applicable
1.2.1 Relevant identified uses
SU3
Emergency telephone
4722591300, 47 21 07 70 00, +47 22591300, +31-10-4877700, 31 88 7558561, +47 23 25 25 84, 31 10 4877700, +61 3 9573 3188
Icons in SDS
Company Information
company name
Wilhelmsen Ships Service AS
e-mail address of the competent person responsible for the Safety Data Sheet
WSS.GLOBAL.SDSINFO@wilhelmsen.com, wss.norway.cs@wilhelmsen.com, wss.global.sdsinfo@wilhelmsen.com, wss.rotterdam@wilhelmsen.com
GHS Information
Signal word
Not Applicable
Section 2
SECTION 2: Hazards identification
No 1272/2008 Classification of the substance or mixture Classification according to regulation (EC) No Non hazardous
Hazard pictograms
Not Applicable
Signal word
Not Applicable
Hazard statements
Not Applicable
Supplemental label elements
EUH208
Contains
1,2-benzisothiazoline-3-one, 5-chloro-2-methyl-4-isothiazolin-3-one, eucalyptol. May produce an allergic reaction EUH210 Safety data sheet available on request.
Precautionary statements
P101 If medical advice is needed, have product container or label at hand. P102 Keep out of reach of children. P103 Read carefully and follow all instructions.
Prevention
Not Applicable
Response
Not Applicable
Storage
Not Applicable
Disposal
Not Applicable Material contains sodium xylenesulfonate, 1,2-benzisothiazoline-3-one, eucalyptol, 5-chloro-2-methyl-4-isothiazolin-3-one.
2.3 Other hazards
1,2-benzisothiazoline-3- Determined to have endocrine-disrupting properties according to Europe Regulation (EU) 528/2012, Europe Regulation (EU) one 2017/2100, and Europe Regulation (EU) 2018/605. This substance/mixture does not meet the criteria for classification as Persistent, Bioaccumulative, and Toxic (PBT) in accordance with Annex XIII, Commission Delegated Regulation (EU) 2017/2100, and Commission Regulation (EU) 2018/605. This substance/mixture does not meet the criteria for classification as very Persistent and very Bioaccumulative (vPvB) in accordance with Annex XIII, Commission Delegated Regulation (EU) 2017/2100, and Commission Regulation (EU) 2018/605. This substance/mixture does not meet the criteria for classification as Persistent, Mobile and Toxic (PMT) in accordance with Commission Delegated Regulation (EU) 2023/707. This substance/mixture does not meet the criteria for classification as very Persistent and very Mobile (vPvM) in accordance with Commission Delegated Regulation (EU) 2023/707. The substance/mixture does not contain components considered to have endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605, nor is it included in the list established under REACH Article 59(1), at Continued... concentrations equal to or greater than 0.1% (w/w). No further product hazard information.
2.1 Classification of the substance or mixture
[1] amendments Legend: 1. Classified by Chemwatch; 2. Classification drawn from Regulation (EU) No 1272/2008 - Annex VI 2.2. Label elements Hazard pictogram(s) Not Applicable Signal word
